Page last updated: 2024-08-23

thymopentin and Melanoma

thymopentin has been researched along with Melanoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baldini, M; Bufalino, R; Cascinelli, N; Clemente, C; Mascheroni, L; Mihm, MC; Zurrida, S1
Baldini, MT; Belli, F; Bufalino, R; Cascinelli, N; Clemente, C; Mascheroni, L; Mihm, MC; Rao, S1
Belli, F; Cascinelli, N; Clemente, C; Lenisa, L; Mascheroni, L1
Agolzer, A; Trevisan, G1

Trials

3 trial(s) available for thymopentin and Melanoma

ArticleYear
Perinodular injection of thymopentin (TP5) in cutaneous and subcutaneous metastases of melanoma.
    Melanoma research, 1993, Volume: 3, Issue:6

    Topics: CD3 Complex; Double-Blind Method; Humans; Injections; Leukocyte Common Antigens; Lymphocyte Subsets; Melanoma; Sclerosis; Skin Neoplasms; Thymopentin

1993
Biological activity and clinical efficacy of intravenous high-dose thymopentin in metastatic melanoma patients.
    Melanoma research, 1996, Volume: 6, Issue:1

    Topics: Adjuvants, Immunologic; Adult; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Immunohistochemistry; Injections, Intravenous; Male; Melanoma; Middle Aged; Pilot Projects; Skin Neoplasms; Thymopentin

1996
Evaluation of clinical efficacy and tolerability of intravenous high dose thymopentin in advanced melanoma patients.
    Melanoma research, 1998, Volume: 8, Issue:1

    Topics: Adjuvants, Immunologic; Adult; Aged; Female; Humans; Immunophenotyping; Injections, Intravenous; Lymphocytes, Tumor-Infiltrating; Male; Melanoma; Middle Aged; Skin Neoplasms; Survival Rate; Thymopentin; Treatment Outcome

1998

Other Studies

1 other study(ies) available for thymopentin and Melanoma

ArticleYear
[Thymopentin in the treatment of cutaneous melanoma].
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 1989, Volume: 124, Issue:5

    Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Immunity, Cellular; Male; Melanoma; Middle Aged; Peptide Fragments; Skin Neoplasms; Thymopentin; Thymopoietins; Thymus Hormones

1989